Related Experiment Videos
Controlled heroin availability in Australia? How and to what end?
1National Centre for Epidemiology and Population Health, Australian National University, Canberra ACT.
The International Journal of the Addictions
|June 1, 1995
Summary
Views on experimental controlled heroin availability trials varied. While most groups anticipated positive outcomes, police expected negative results, highlighting diverse stakeholder interests in drug policy research.
Area of Science:
- Public Health
- Sociology
- Criminology
Background:
- Public health policies increasingly explore innovative approaches to address substance use disorders.
- Experimental controlled drug availability trials are proposed as a method to study harm reduction strategies.
- Understanding diverse stakeholder perspectives is crucial for the ethical and effective design of such trials.
Purpose of the Study:
- To assess the opinions of the general public, police, service providers, and users/ex-users regarding trial design and outcomes for controlled heroin availability.
- To identify areas of agreement and disagreement among key stakeholder groups concerning experimental drug policies.
Main Methods:
- A systematic consultation process was employed to gather views from diverse community samples.
- Surveys and interviews likely used to collect data on perceptions of trial design and potential consequences.
Main Results:
- Substantial agreement was found among all groups regarding the design of experimental trials.
- Community members, service providers, and users/ex-users generally predicted positive trial outcomes.
- The police sample predominantly anticipated negative outcomes from such trials.
Conclusions:
- Systematic consultation with key stakeholders is valuable for policy development and identifying potential challenges.
- Divergent interests among groups, such as law enforcement versus public health advocates, must be considered in drug policy research.
- The findings underscore the importance of inclusive dialogue in shaping evidence-based harm reduction strategies.